Medical Equipment & Supplies

Poly Medicure Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 100 filings·Updated 13 Oct 2026
Showing 10 of 100 filings.
13 Oct 20262 filings
Company UpdateCertificate under SEBI (Depositories and Participants) Regulations, 2018

Poly Medicure Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 14:24View Source
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dematerialisation processing completed within 15 days; depository and exchanges updated.

Dematerialisation processing status

  • Dematerialisation requests received during the period were processed and confirmed to depositories within 15 days.
  • Certificates for dematerialisation were mutilated and cancelled after verification, depository registered owner substituted within 15 days.
  • Updates were reflected with the depository and every stock exchange where listed, and Register of Members updated.
Filed 14:21View Source
28 Sept 20262 filings
Insider Trading / SASTClosure of Trading Window

Poly Medicure Limited — Closure of Trading Window

Poly Medicure Limited — Closure of Trading Window

Filed 18:50View Source
Insider Trading / SASTClosure of Trading Window

Poly Medicure Ltd — Closure of Trading Window

Poly Medicure Ltd — Closure of Trading Window

Filed 18:27View Source
24 Sept 20261 filing
Company UpdateGeneral

Poly Medicure schedules one-on-one investor meetings on 30 September 2026 at Ballabhgarh plant

Investor meeting

  • Intimation of one-on-one investor meetings with analysts on 30 September 2026.
  • Venue: Plant visit at 117 Sector-59, HSIIDC Industrial Area, Ballabhgarh, Faridabad.
  • Format: One-on-one; Investor: Avendus Spark.
Filed 17:12View Source
23 Sept 20262 filings
Company UpdateGeneral

Poly Medicure to hold one-on-one investor meeting with Dam Capital on Sept 25, 2026

Investor Meet Schedule

  • One-on-one investor meeting with Dam Capital on 25 September 2026 at 11:00 AM (Virtual).
  • Schedule subject to change; no UPSI to be shared.
  • Confirmation received on short notice; information available on company website.
Filed 19:10View Source
Company UpdateGeneral

Poly Medicure schedules one-on-one investor meeting with Dam Capital on 25 September 2026

Investor meeting details

  • One-on-one investor meeting with Dam Capital on 25 Sep 2026 at 11:00 AM (virtual).
  • Schedule subject to change; no unpublished price-sensitive information will be shared.
  • Confirmation to the schedule received on short notice.
Filed 18:55View Source
21 Sept 20261 filing
Company UpdateGeneral

Poly Medicure schedules one-on-one investor meet with ICICI Securities PMS

Investor meeting details

  • Purpose: one-on-one meetings with ICICI Securities PMS to discuss company updates.
  • Meeting Date: Thursday, 2-l'h September 2026, 04:00 PM.
  • Venue: Registered Office, 232-8, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi.
  • Participants: ICICI Securities PMS.
  • Schedule is subject to change due to exigencies.
  • No Unpublished Price Sensitive Information will be shared during the meeting.
Filed 18:50View Source
18 Sept 20261 filing
Company UpdateGeneral

Poly Medicure schedules one-on-one investor meeting with Axis Max Life on Sept 23, 2026

Investor meeting details

  • One-on-one investor meeting with Axis Max Life on 23 September 2026 at 4:00 PM; venue EJI.
Filed 17:31View Source
7 Sept 20261 filing
AGM/EGMAGM

Poly Medicure Ltd AGM 2026 approves financials, dividend, director re-appointments, and cost auditor remuneration

AGM details

  • Date/time: 5 Sep 2026, 11:00 IST; mode: VC/OAVM.
  • Cut-off date for voting: 29 Aug 2026.
  • Deemed venue: Registered Office.

Key resolutions

  • Item 1: Adoption of audited standalone and consolidated financial statements (ordinary).
  • Item 2: Dividend declaration on equity shares (ordinary).
  • Item 3: Re-appointment of Rishi Baid as director (ordinary).
  • Item 4: Re-appointment of Devendra Raj Mehta as Non-Executive Non-Independent director (special).
  • Item 5: Remuneration of Cost Auditor for FY 2026-27 (ordinary).

Voting results

  • Item 1: Passed; 99.999% in favour, 0.0001% against.
  • Item 2: Passed; 99.9982% in favour, 0.0018% against.
  • Item 3: Passed; 99.2029% in favour, 0.7971% against.
  • Item 4: Passed; 99.0791% in favour, 0.9209% against.
  • Item 5: Passed; 99.9999% in favour, 0.0001% against.

Dividends

  • Dividend declared on equity shares for FY 2025-26; amount per share not disclosed.

Director changes

  • Rishi Baid re-appointed as director; retires by rotation.
  • Devendra Raj Mehta re-appointed as Non-Executive Non-Independent director (Special).

Auditors

  • Remuneration of Cost Auditor approved for FY 2026-27.
Filed 19:38View Source
Showing 10 of 100 filings